---
figid: PMC4521272__JCTH-1-039-g001
figlink: /pmc/articles/PMC4521272/figure/f01/
number: F1
caption: Upon viral infection, cytoplasmic viral sensors (RIG-I) and toll-like receptors
  (TLRs) detect viral pathogens, which results in IFNβ and IFNλs gene activation via
  the adaptor molecule IPS-1. IFNβ binds to type I IFN receptors, whereas IFNλs bind
  to type III IFN receptors comprising IL10R–IL28R receptor complexes. Both receptors
  activate the Jak–STAT pathway, which upregulates a large number of ISGs by activating
  the IFN-stimulated response element (ISRE). IL28B promoter activity is reportedly
  lower with unfavorable IL28B SNPs.RIG-I and ISG expressions in patients with unfavorable
  IL28B genotypes tend to be high at baseline and are insufficiently induced by exogenous
  IFN administration, resulting in poor treatment outcomes with IFN-based therapy.
  IFNλ4 is created by ss469415590 variant (ΔG), which is in high linkage disequilibrium
  with rs12979860. Although IFNλ4 induces ISGs by activating ISRE, this preactivation
  of IFN signaling impairs HCV clearance and prevents further activation by exogenous
  type I and type III IFNs.
pmcid: PMC4521272
papertitle: Polymorphism Near the Interleukin-28B Gene and Anti-Hepatitis C Viral
  Response.
reftext: Yasuhiro Asahina, et al. J Clin Transl Hepatol. 2013 Sep;1(1):39-44.
pmc_ranked_result_index: '69292'
pathway_score: 0.9518144
filename: JCTH-1-039-g001.jpg
figtitle: Polymorphism Near the Interleukin-28B Gene and Anti-Hepatitis C Viral Response
year: '2013'
organisms: Homo sapiens
ndex: 7b202bbc-deee-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4521272__JCTH-1-039-g001.html
  '@type': Dataset
  description: Upon viral infection, cytoplasmic viral sensors (RIG-I) and toll-like
    receptors (TLRs) detect viral pathogens, which results in IFNβ and IFNλs gene
    activation via the adaptor molecule IPS-1. IFNβ binds to type I IFN receptors,
    whereas IFNλs bind to type III IFN receptors comprising IL10R–IL28R receptor complexes.
    Both receptors activate the Jak–STAT pathway, which upregulates a large number
    of ISGs by activating the IFN-stimulated response element (ISRE). IL28B promoter
    activity is reportedly lower with unfavorable IL28B SNPs.RIG-I and ISG expressions
    in patients with unfavorable IL28B genotypes tend to be high at baseline and are
    insufficiently induced by exogenous IFN administration, resulting in poor treatment
    outcomes with IFN-based therapy. IFNλ4 is created by ss469415590 variant (ΔG),
    which is in high linkage disequilibrium with rs12979860. Although IFNλ4 induces
    ISGs by activating ISRE, this preactivation of IFN signaling impairs HCV clearance
    and prevents further activation by exogenous type I and type III IFNs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA6
  - IRF3
  - IFNA1
  - IFNA7
  - IFNA4
  - MAVS
  - RELA
  - IFNA10
  - IFNA2
  - STAT1
  - IFNA5
  - IFNA8
  - IL10RB
  - IFNA14
  - NFKB2
  - IRF7
  - IFNA13
  - TLR7
  - DDX58
  - NFKB1
  - IFNB1
  - IFNA21
  - TLR3
  - IFNA16
  - IFNAR1
  - IFNA17
  - RELB
  - REL
genes:
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IPS-1
  symbol: IPS-1
  source: hgnc_alias_symbol
  hgnc_symbol: MAVS
  entrez: '57506'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: ISGF3
  symbol: ISGF-3
  source: hgnc_alias_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: IFNA4
  symbol: IFNA4
  source: hgnc_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: IL10R2
  symbol: IL-10R2
  source: hgnc_alias_symbol
  hgnc_symbol: IL10RB
  entrez: '3588'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: TLR7
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: RIG-I
  symbol: RIG-I
  source: hgnc_alias_symbol
  hgnc_symbol: DDX58
  entrez: '23586'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: IFNB
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: TLR3
  symbol: TLR3
  source: hgnc_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: IFNAR1
  symbol: IFNAR1
  source: hgnc_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
chemicals: []
diseases: []
figid_alias: PMC4521272__F1
redirect_from: /figures/PMC4521272__F1
figtype: Figure
---
